<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02866578</url>
  </required_header>
  <id_info>
    <org_study_id>2016-03</org_study_id>
    <secondary_id>2016-A00352-49</secondary_id>
    <nct_id>NCT02866578</nct_id>
  </id_info>
  <brief_title>Open Lung Protective Ventilation in Cardiac Surgery</brief_title>
  <acronym>PROVECS</acronym>
  <official_title>Open Lung Protective Ventilation During Cardiac Surgery With Cardiopulmonary Bypass : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery with cardiopulmonary bypass (CPB) frequently induces post-operative
      respiratory dysfunction. The post-operative pulmonary complications (PPCs) significantly
      increase the peri-operative morbidity and require invasive treatments during longer and more
      expensive ICU stays. A specific pathophysiology involving general anesthesia and CPB-related
      factors (inflammation, pulmonary ischemia) has been clearly demonstrated and pulmonary
      atelectasis seems to play a central role in the occurence of these PPCs. The open lung
      approach is a ventilation strategy that aims to &quot;open the lung and keep it open&quot; using
      different ventilatory settings. The efficacy of that strategy is not demonstrated in the
      global surgical population. However, its application in the perioperative care of cardiac
      surgery patients could be of great interest by counteracting the development of atelectasis.

      The purpose of this multicentre, double blinded, randomized controlled study is to evaluate
      the influence of a perioperative multimodal protective ventilation strategy based on the
      &quot;open lung approach&quot; on postoperative outcomes during the first 7 days following cardiac
      surgery. Participating centres will include 500 adult patients undergoing scheduled on-pump
      cardiac surgery. The open lung approach will combine recruitment maneuvers (RM), positive end
      expiratory pressure (PEEP) at 8 cmH2O from intubation to detubation and continuation of
      ultraprotective ventilation during CPB. It will be compared to a conventional approach
      without RM, with PEEP at 2 cmH2O and discontinuation of ventilation during CPB. The primary
      endpoint is any post-operative pulmonary complication. The secondary endpoints are any
      post-operative extra-pulmonary complications and the number of ICU-free days to day 7.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pulmonary complications defined as a composite endpoint</measure>
    <time_frame>first 7 days post-operatively.</time_frame>
    <description>Mild hypoxemia Moderate hypoxemia Severe hypoxemia Severe bronchospam Radiological atelectasis Respiratory acidosis Pneumonia Pleural effusion Acute Respiratory Distress Syndrome Need for reintubation Need for reintubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative extrapulmonary complication</measure>
    <time_frame>First 7 days post operatively</time_frame>
    <description>Systemic inflammatory response syndrome Sepsis Septic chock Mediastinitis Pericardial tamponade Surgical bleeding Acute kidney failure (KDIGO stage 2 or 3) Postoperative atrial fibrillation Cardiogenic chock Delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU free Days</measure>
    <time_frame>First 7 days post operatively</time_frame>
    <description>Days alive and free from the need of intensive care</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">494</enrollment>
  <condition>Hypoxemia</condition>
  <arm_group>
    <arm_group_label>Open lung protective ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recruitment maneuvers (30 cmH2O during 30 seconds) after intubation, after CPB initiation, before aortic declamping and at ICU arrival.
PEEP at 8 cmH2O.
Ultraprotective ventilation during CPB: PEEP 8 cmH2O, Tidal volume 3mL/kg, Respiratory rate 12 cycles per minute, FiO2 40%.
Assigned intervention - Procedure: patients are randomized and ventilated with the open lung strategy from intubation to detubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional strategy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No recruitment maneuvers. PEEP at 2 cmH2O. During CPB: continuous positive pressure at 2 cmH2O.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open lung protective ventilation strategy</intervention_name>
    <arm_group_label>Open lung protective ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery planned with CPB and sternotomy.

          -  Age &gt; 18 years old.

        Exclusion Criteria:

          -  Urgent surgery : cardiac transplantation, aortic dissection, active endocarditis.

          -  Aortic arch surgery with circulatory arrest.

          -  LVAD surgery.

          -  Acute or chronic preoperative hypoxemia (PaO2 &lt; 65 mmHg in air).

          -  Preoperative shock state requiring catecholamines.

          -  LVEF &lt; 40%.

          -  Pulmonary hypertension with systolic pulmonary artery pressure &gt; 50 mmHg.

          -  Severe right ventricular dysfunction (TDI tricuspid annular systolic velocity &lt; 10
             cm.s-1).

          -  Chronic kidney disease (Glomerular filtration rate &lt; 30 mL/min).

          -  Body Mass Index &gt; 35kg/m2.

          -  Patient's refusal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>AP-HM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David LAGIER, MD</last_name>
    <phone>+334 91 38 99 89.</phone>
    <email>david.lagier@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Louis Pradel HCL</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc Fellahi, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David LAGIER, MD</last_name>
      <email>david.lagier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>David LAGIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard CHOLLEY, MD/PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Luc FELLAHI, MD/PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU MontpellierHôpital Arnaud de VILLENEUVE</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal COLSON, MD/PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gianluca Samarani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou AP-HP</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard CHOLLEY, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François FISCHER, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>August 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2016</study_first_posted>
  <last_update_submitted>July 6, 2017</last_update_submitted>
  <last_update_submitted_qc>July 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

